The 5-year cumulative HCC incidence rate was 6.1–7.3% for non-cirrhotic CHB patients, with elevated HBV DNA levels plus mildly elevated alanine aminotransferase levels. The gene discussed is GPT; the disease is hepatocellular carcinoma.